Positive trial results for dexamethasone in treating COVID-19 patients have been welcomed by the off-patent industry as demonstrating the potential for repurposing existing generic medicines to help in the fight against the coronavirus pandemic.
With the World Health Organization citing the results from the UK’s “RECOVERY” – or Randomized Evaluation of COVID-19 Therapy –...